We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

FTS:TSXFortis Inc. Analysis

Data as of 2026-03-10 - not real-time

CA$78.72

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Fortis Inc. (FTS) is trading at C$78.72, comfortably above its 20‑day (C$77.51), 50‑day (C$74.32) and 200‑day (C$70.19) moving averages, indicating a bullish price trend. The RSI sits at 66.8, signaling an overbought condition that could temper short‑term upside, while the MACD histogram is slightly negative (-0.08) and the signal line is bearish, suggesting a potential near‑term pause. The stock enjoys a solid dividend yield of 3.23% and has just extended a 52‑year streak of dividend increases, reinforcing its appeal to income investors. However, valuation metrics are stretched: the forward P/E of 20.4 exceeds the industry average of 20.86, and the DCF‑derived fair value of C$26.06 is far below the current price, pointing to an overvalued market level.
Fundamentally, Fortis delivers stable earnings with a profit margin of 14.8% and a ROE of 7.6%, but its balance sheet is heavily leveraged (debt‑to‑equity ~134) and free cash flow is negative (≈‑C$2.6 B). The high payout ratio of 73% combined with limited cash generation raises questions about dividend sustainability in a rising‑rate environment. Nonetheless, the regulated utility business provides predictable cash flows and low sector volatility, supporting a long‑term investment case if the stock price corrects toward intrinsic values.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near resistance at C$79.05
  • Overbought RSI and bearish MACD signal
  • High valuation relative to DCF fair value

Medium Term

1–3 years
Neutral
Model confidence: 7/10

Key Factors

  • Sustained dividend growth and 3.23% yield
  • Elevated leverage and negative free cash flow
  • Stable regulated earnings supporting cash flow

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • 52‑year dividend increase streak
  • Low sector volatility and predictable cash flows
  • Potential price correction toward intrinsic value

Key Metrics & Analysis

Financial Health

Revenue Growth4.40%
Profit Margin14.78%
P/E Ratio23.2
ROE7.58%
ROA3.01%
Debt/Equity134.11
P/B Ratio1.8
Op. Cash FlowCA$4.1B
Free Cash FlowCA$-2633250048
Industry P/E20.9

Technical Analysis

TrendBullish
RSI66.8
SupportCA$73.25
ResistanceCA$79.05
MA 20CA$77.51
MA 50CA$74.32
MA 200CA$70.19
MACDBearish
VolumeStable
Fear & Greed Index81.02

Valuation

Fair ValueCA$26.06
Target PriceCA$75.50
Upside/Downside-4.09%
GradeOvervalued
TypeValue
Dividend Yield3.23%

Risk Assessment

Beta-0.14
Volatility16.33%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.